Altamira Therapeutics AG

Altamira Therapeutics is developing and supplying peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues (xPhore™ platform). The versatile delivery platform is suited for different nucleic acid modalities, including siRNA, mRNA, circRNA, as well as DNA.

Location

Canton

Facts & figures

  • Type of organization
    Public company
  • Year of foundation
    2003
  • Number of employees in Switzerland
    1-9

You may also be interested in